General Information
Version
3
Revision date
2011-07-12
Product name
IVOMEC PLUS Broad-spectrum Antiparasitic Injection for
supplier name
Merial Australia Pty Ltd
Icons in SDS
Company Information
company name
Merial Australia Pty Ltd
Section 2
SECTION 2: Hazards identification
Classified as hazardous (Toxic T) according to the Australian Safety and Compensation Commission (Safe Work Australia) Approved Criteria for Classifying Hazardous Substances [NOHSC:1008(2004)]. Not classified as Dangerous Goods according to the ADG Code.
Hazard statements
Hazard) TOXIC IF SWALLOWED (R25) HARMFUL BY INHALATION AND IN CONTACT WITH SKIN (R20/21) IRRITATING TO EYES AND SKIN (R36/38) VERY TOXIC TO AQUATIC ORGANISMS (R50) Safety phrase(s): KEEP OUT OF THE REACH OF CHILDREN (S2)
Precautionary statements
KEEP AWAY FROM FOOD, DRINK AND ANIMAL FEEDING STUFFS. (S13) WHEN USING, DO NOT EAT OR DRINK (S20) AFTER CONTACT WITH SKIN, WASH IMMEDIATELY WITH PLENTY OF WATER. (S28) DO NOT EMPTY INTO DRAINS (S29) IF SWALLOWED, SEEK MEDICAL ADVICE IMMEDIATELY AND SHOW THE CONTAINER OR LABEL. (S46)
SUSDP Classification
POISONS SCHEDULE: 5 ADG CODE CLASSIFICATION: Not a Dangerous Goods UN No. None LOCAL EFFECTS: TARGET ORGANS: See note to physician in Section 4. INHALATION: Not a likely route of entry. At the concentration of active ingredient in this product, unlikely to be harmful. SKIN CONTACT: May be irritating with prolonged or frequent contact. Solvent may be absorbed through the skin. EYE CONTACT: Irritating. INGESTION: Harmful. May cause dilated pupils (mydriasis), in-coordination, drowsiness, slow breathing, nausea, vomiting, tachycardia, somnolence, tremors and blood pressure variations. No toxic effects reported in humans up to 2000µ/kg bw. Ivermectin can be excreted in milk.
Potential chronic health
Not sensitising. At doses toxic to the mother, pure ivermectin is a reproductive toxin in mice and rats, however, in rabbits, ivermectin is foetotoxic at doses not toxic to the mother. Rats exposed in utero, through lactation and for an additional 3 months, showed signs of intravascular haemolysis. CARCINOGEN STATUS: Not classified by NOHSC, NTP or IARC